MARKET

ARCT

ARCT

Arcturus Therape
NASDAQ
20.27
-0.32
-1.55%
After Hours: 20.27 0 0.00% 16:00 01/30 EST
OPEN
20.23
PREV CLOSE
20.59
HIGH
20.97
LOW
20.01
VOLUME
228.22K
TURNOVER
0
52 WEEK HIGH
31.41
52 WEEK LOW
11.70
MARKET CAP
537.01M
P/E (TTM)
-3.6489
1D
5D
1M
3M
1Y
5Y
Tracking Cathie Wood's ARK Invest 13F Portfolio - Q4 2022 Update
Seeking Alpha · 4d ago
Arcturus Therapeutics (ARCT) Investor Presentation - Slideshow
Seeking Alpha · 01/12 16:21
ARCT, BLI and FREQ are among after hour mover
Seeking Alpha · 01/09 22:53
CRSP, ARCT and CHRS are among after hour mover
Seeking Alpha · 01/03 23:01
Arcturus Therapeutics Files $500 Million Mixed Shelf
Arcturus Therapeutics Files $500 Million Mixed Shelf
MT Newswires · 12/27/2022 03:11
BRIEF-Arcturus Therapeutics Files Mixed Shelf For Up To $500 Mln
Reuters · 12/23/2022 22:04
Arcturus Therapeutics's Return On Capital Employed Overview
Benzinga · 12/15/2022 14:49
BRIEF-Arcturus Appoints John Markels To Its Board Of Directors
Reuters · 12/13/2022 13:46
More
About ARCT
Arcturus Therapeutics Holdings Inc. is a late-stage global clinical messenger ribonucleic acid (mRNA) medicines company. The Company is focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. In addition to its mRNA platform, the Company's lipid nanoparticle (LNP) delivery system, LUNAR, has the potential to enable multiple nucleic acid medicines, and its self-amplifying mRNA technology (Self-Transcribing and Replicating RNA (STARR), technology) has the potential to provide longer-lasting RNA and sustained protein expression at lower dose levels. The Company's products under developmental stage using STARR technology are ARCT-021, ARCT-154 and ARCT-165. Its COVID-19 vaccine candidate, ARCT-021, which is based on its STARR technology platform is through Phase II clinical trials. Its LUNAR-FLU Vaccine consists of Liver Franchise ARCT-810 (LUNAR-OTC) and Lung Franchise ARCT-032 (LUNAR-CF).

Webull offers kinds of Arcturus Therapeutics Holdings Inc stock information, including NASDAQ:ARCT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ARCT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ARCT stock methods without spending real money on the virtual paper trading platform.